Osteoporosis, an underdiagnosed disease

JAMA

Volumn 286, Issue 22, 2001, Pages 2865-2866

  Chesnut III, C H ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

BONE DENSITY; BONE MINERAL; DENSITOMETRY; EDITORIAL; ESTROGEN THERAPY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0035852128     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.22.2865     Document Type: Editorial

References (11)

1. Design of NORA, the National Osteoporosis Risk Assessment Program
2. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment
3. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture
4. How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?
5. The incidence of clinically diagnosed vertebral fractures
6. Validity of self-report of fractures
7. The accuracy of self-report of fractures in elderly women
8. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification
9. Fracture risk assessment across peripheral sites: Results from the NORA study
10. Prediction of fracture risk in postmenopausal Caucasian women with peripheral bone densitometry: Evidence from National Osteoporosis Risk Assessment (NORA)